Evidence map›Paper›PMID 29702620›Full record

ArticleMaterials (Basel, Switzerland)2018

C

Matteo Di Giosia, Francesco Valle, Andrea Cantelli, Andrea Bottoni, Francesco Zerbetto, Matteo Calvaresi

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Enhanced Uptake and Phototoxicity of CNanomaterials (Basel, Switzerland) · 2022
    Article
  7. Fullerenes against COVID-19: Repurposing CMolecules (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Investigating the Size-Dependent Binding of Pristine nCMaterials (Basel, Switzerland) · 2021
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matteo Di GiosiaDipartimento di Chimica "G. Ciamician", Università di Bologna, via F. Selmi 2, 40126 Bologna, Italy. matteo.digiosia2@unibo.it.ORCID 0000-0003-3494-298X
Francesco ValleIstituto per lo Studio dei Materiali Nanostrutturati (CNR-ISMN), Consiglio Nazionale delle Ricerche, via P. Gobetti 101, 40129 Bologna, Italy. f.valle@ismn.cnr.bo.it.
Andrea CantelliDipartimento di Chimica "G. Ciamician", Università di Bologna, via F. Selmi 2, 40126 Bologna, Italy. a.cantelli@unibo.it.
Andrea BottoniDipartimento di Chimica "G. Ciamician", Università di Bologna, via F. Selmi 2, 40126 Bologna, Italy. andrea.bottoni@unibo.it.
Francesco ZerbettoDipartimento di Chimica "G. Ciamician", Università di Bologna, via F. Selmi 2, 40126 Bologna, Italy. francesco.zerbetto@unibo.it.
Matteo CalvaresiDipartimento di Chimica "G. Ciamician", Università di Bologna, via F. Selmi 2, 40126 Bologna, Italy. matteo.calvaresi3@unibo.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high hydrophobicity of fullerenes and the resulting formation of aggregates in aqueous solutions hamper the possibility of their exploitation in many technological applications. Noncovalent bioconjugation of fullerenes with proteins is an emerging approach for their dispersion in aqueous media. Contrary to covalent functionalization, bioconjugation preserves the physicochemical properties of the carbon nanostructure. The unique photophysical and photochemical properties of fullerenes are then fully accessible for applications in nanomedicine, sensoristic, biocatalysis and materials science fields. However, proteins are not universal carriers. Their stability depends on the biological conditions for which they have evolved. Here we present two model systems based on pepsin and trypsin. These proteins have opposite net charge at physiological pH. They recognize and disperse C

Indexed as

bioconjugationchemical stabilityfullerenesnanobiotechnologynanohybrids

Identifiers

PMID29702620
PMCPMC5978068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.